Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
Crossref DOI link: https://doi.org/10.1186/s13045-016-0328-4
Published Online: 2016-09-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alexander, Gregory S.
Palmer, Joshua D.
Tuluc, Madalina
Lin, Jianqing
Dicker, Adam P.
Bar-Ad, Voichita
Harshyne, Larry A
Louie, Jennifer
Shaw, Colette M.
Hooper, D. Craig
Lu, Bo
Funding for this research was provided by:
Merck Sharp and Dohme (N/A)
